サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/29 | 5,090 | 5,090 | 5,000 | 5,010 | -70 | -1.4% | 65,900 |
2021/06/28 | 5,070 | 5,100 | 5,030 | 5,080 | +30 | +0.6% | 78,500 |
2021/06/25 | 5,000 | 5,070 | 5,000 | 5,050 | +50 | +1% | 70,500 |
2021/06/24 | 4,950 | 5,040 | 4,950 | 5,000 | +15 | +0.3% | 53,600 |
2021/06/23 | 4,945 | 5,030 | 4,925 | 4,985 | +55 | +1.1% | 111,700 |
2021/06/22 | 4,950 | 4,970 | 4,895 | 4,930 | +80 | +1.6% | 66,000 |
2021/06/21 | 4,835 | 4,895 | 4,810 | 4,850 | -25 | -0.5% | 159,600 |
2021/06/18 | 4,920 | 5,020 | 4,870 | 4,875 | -45 | -0.9% | 289,900 |
2021/06/17 | 5,020 | 5,030 | 4,880 | 4,920 | -65 | -1.3% | 177,700 |
2021/06/16 | 4,970 | 5,020 | 4,960 | 4,985 | -15 | -0.3% | 91,200 |
2021/06/15 | 5,010 | 5,050 | 4,980 | 5,000 | -10 | -0.2% | 56,400 |
2021/06/14 | 5,050 | 5,050 | 4,990 | 5,010 | ±0 | ±0% | 41,600 |
2021/06/11 | 5,080 | 5,080 | 4,980 | 5,010 | -40 | -0.8% | 92,000 |
2021/06/10 | 5,040 | 5,070 | 4,990 | 5,050 | +50 | +1% | 85,800 |
2021/06/09 | 4,950 | 5,040 | 4,945 | 5,000 | +110 | +2.2% | 85,000 |
2021/06/08 | 4,900 | 4,925 | 4,860 | 4,890 | +35 | +0.7% | 53,700 |
2021/06/07 | 4,845 | 4,885 | 4,835 | 4,855 | -20 | -0.4% | 95,600 |
2021/06/04 | 4,850 | 4,880 | 4,815 | 4,875 | +30 | +0.6% | 83,600 |
2021/06/03 | 4,795 | 4,865 | 4,755 | 4,845 | +85 | +1.8% | 116,500 |
2021/06/02 | 4,720 | 4,785 | 4,715 | 4,760 | -10 | -0.2% | 148,100 |
2021/06/01 | 4,845 | 4,850 | 4,750 | 4,770 | -10 | -0.2% | 99,500 |
2021/05/31 | 4,745 | 4,865 | 4,740 | 4,780 | -35 | -0.7% | 134,300 |
2021/05/28 | 4,825 | 4,825 | 4,775 | 4,815 | +50 | +1% | 105,700 |
2021/05/27 | 4,815 | 4,845 | 4,765 | 4,765 | -40 | -0.8% | 177,500 |
2021/05/26 | 4,750 | 4,845 | 4,745 | 4,805 | -5 | -0.1% | 137,500 |
2021/05/25 | 4,850 | 4,905 | 4,765 | 4,810 | -65 | -1.3% | 132,000 |
2021/05/24 | 4,835 | 4,915 | 4,810 | 4,875 | ±0 | ±0% | 88,800 |
2021/05/21 | 4,885 | 4,935 | 4,835 | 4,875 | -25 | -0.5% | 129,700 |
2021/05/20 | 4,910 | 4,960 | 4,890 | 4,900 | -35 | -0.7% | 79,900 |
2021/05/19 | 4,895 | 4,990 | 4,895 | 4,935 | ±0 | ±0% | 125,200 |
2021/05/18 | 4,885 | 4,955 | 4,870 | 4,935 | +75 | +1.5% | 64,600 |
2021/05/17 | 4,915 | 4,925 | 4,845 | 4,860 | -25 | -0.5% | 76,800 |
2021/05/14 | 4,860 | 4,910 | 4,820 | 4,885 | +70 | +1.5% | 64,600 |
2021/05/13 | 4,815 | 4,885 | 4,805 | 4,815 | +5 | +0.1% | 115,800 |
2021/05/12 | 5,130 | 5,170 | 4,735 | 4,810 | -420 | -8% | 330,700 |
2021/05/11 | 5,330 | 5,330 | 5,210 | 5,230 | -100 | -1.9% | 95,100 |
2021/05/10 | 5,190 | 5,340 | 5,180 | 5,330 | +80 | +1.5% | 109,900 |
2021/05/07 | 5,270 | 5,300 | 5,220 | 5,250 | -40 | -0.8% | 76,800 |
2021/05/06 | 5,210 | 5,360 | 5,190 | 5,290 | +30 | +0.6% | 124,900 |
2021/04/30 | 5,190 | 5,310 | 5,170 | 5,260 | +50 | +1% | 171,000 |
2021/04/28 | 5,180 | 5,240 | 5,170 | 5,210 | +10 | +0.2% | 81,800 |
2021/04/27 | 5,200 | 5,210 | 5,160 | 5,200 | ±0 | ±0% | 75,800 |
2021/04/26 | 5,210 | 5,210 | 5,130 | 5,200 | ±0 | ±0% | 77,800 |
2021/04/23 | 5,220 | 5,250 | 5,200 | 5,200 | -20 | -0.4% | 40,700 |
2021/04/22 | 5,210 | 5,250 | 5,180 | 5,220 | +60 | +1.2% | 67,700 |
2021/04/21 | 5,180 | 5,210 | 5,060 | 5,160 | ±0 | ±0% | 140,100 |
2021/04/20 | 5,240 | 5,250 | 5,160 | 5,160 | -160 | -3% | 88,100 |
2021/04/19 | 5,370 | 5,390 | 5,290 | 5,320 | -60 | -1.1% | 72,600 |
2021/04/16 | 5,270 | 5,410 | 5,240 | 5,380 | +140 | +2.7% | 146,800 |
2021/04/15 | 5,230 | 5,320 | 5,190 | 5,240 | +80 | +1.6% | 124,600 |
951~
1000
件表示中 / 1010件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 177,300円 | +5.9% | +24.5% | 3.10% | 11.77倍 | 1.11倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
日本新薬 | 342,800円 | +8.0% | -15.3% | 3.62% | 9.63倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 172,200円 | +5.0% | +1.5% | 0.00% | 14.72倍 | 3.92倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 388,000円 | +3.6% | +6.1% | 3.09% | 13.07倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム